1. Market Research
  2. > Healthcare Market Trends
  3. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Austria

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Austria
AUSTRIA 1
HEALTHCARE SYSTEM1
Facts and Figures 1
Market Indicators2
Provision and Funding 4
Health Insurance System 4
Regulation and Funding 4
Ambulatory and Hospital Care5
PRICING5
Prescription Drugs5
Reimbursed Drugs5
Non-reimbursed Drugs 7
Generic Drugs 7
Hospital Drugs8
Discounts 8
OTC Drugs 8
REIMBURSEMENT 8
Admission to Reimbursement 8
Application 8
Process9
Decision10
Appeals10
Individual Reimbursement 11
Calls for Reform11
Reimbursement Categories 11
Reimbursement ‘Box' System 11
Negative List12
Reimbursement Prices13
Hospital Reimbursement13
Formularies13
Funding14
Changes in Reimbursement Status 14
Manufacturers Applications 14
HVB 14
Changes in Reimbursement Prices 15
Red Box 16
Green/Yellow Boxes 16
Off-Patent Originals and Generics 16
PHARMACOECONOMICS17
Pharmacoeconomic Requirements17
PRICE BUILD UP 18
Wholesalers 18
Margins 18
Austria, Pharmaceutical Pricing and Reimbursement Concise Guide
v
Discounts 19
Background19
Retail Pharmacies 20
Margins 20
Discounts 20
Background23
E-pharmacy 24
Other Developments24
Drugstores 24
Dispensing Doctors 25
Sales Tax25
COST CONTAINMENT 25
Industry Paybacks25
Promotional Costs26
Patient Co-payments26
Pharmaceuticals 26
Healthcare 26
Prescribing Controls27
National Level27
Upper Austria29
Salzburg and Burgenland 30
Vienna30
Generics30
INN Prescribing and Generic Substitution30
Generics Promotion31
Rx-to-OTC Switches 31
Switches 31
OTC Market 32
Parallel Trade32
FUTURE DEVELOPMENTS 32
Outlook32
Calls for Pricing and Reimbursement Reform 32
DRG System Reform33
Pharmacy Establishment Rules33
Debt Management 33
Healthcare Reform 33
ELGA Implementation 34
NAMES and ADDRESSES 35

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary Diabetic Foot Ulcer (DFU) and Diabetic Foot Infection (DFI) market is set to triple in value from $292.1 Million ...


Download Unlimited Documents from Trusted Public Sources

Health Care Provider Industry in the UK

  • March 2017
    163 pages
  • Health Care Pro...  

    Hospital  

    Anti-Infective  

  • United Kingdom  

    Europe  

View report >

Health Care Provider Industry in the UK

  • March 2017
    43 pages
  • Health Care Pro...  

  • United Kingdom  

    Europe  

View report >

Health Facility Industry in the US

  • March 2017
    15 pages
  • Health Facility  

    Hospital  

  • United States  

View report >

Diabetes Statistics

3 days ago

Related Market Segments :

Health Care Provider
Hospital
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.